tiprankstipranks
Advertisement
Advertisement

Cambi Wins Major Thermal Hydrolysis Contract for Auckland’s Rosedale Plant

Story Highlights
  • Cambi secures a large thermal hydrolysis contract for Watercare’s Rosedale wastewater plant in Auckland.
  • The project boosts biogas output, cuts biosolids and emissions, with operations planned to start in 2030.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cambi Wins Major Thermal Hydrolysis Contract for Auckland’s Rosedale Plant

Meet Samuel – Your Personal Investing Prophet

Cambi ASA ( (DE:3W7) ) just unveiled an announcement.

Cambi has signed a contract with Watercare Services to deliver two thermal hydrolysis systems for the Rosedale wastewater treatment plant in Auckland, marking a strategically important project in a growing market. The deal starts with an engineering phase, with manufacturing expected to follow after a later notice to proceed, and the engineering portion classified as a small contract while the total project ranks as a large contract valued between NOK 100 million and 200 million.

The project will expand digestion capacity without new digesters, support higher biogas production, reduce biosolids and carbon footprint, and lower life-cycle asset costs at Watercare’s second-largest wastewater plant. Equipment delivery is currently scheduled for 2028 with operations targeted for 2030, supporting Watercare’s broader programme to increase treatment capacity, improve performance and cut emissions as wastewater flows to the site grow.

More about Cambi ASA

Cambi ASA is a global supplier of biogas technology and solutions for wastewater treatment plants and anaerobic digestion facilities. The company specialises in thermal hydrolysis processes that boost renewable energy output, improve dewatering, cut operating costs and reduce greenhouse gas emissions, serving both new and existing digestion sites worldwide.

Average Trading Volume: 55,295

Current Market Cap: NOK3.12B

Find detailed analytics on 3W7 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1